OPKO Health, Inc. (OPK)
Healthcare • Diagnostics & Research
StockNasdaqGSUnited StatesUS68375N1037
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by OPKO Health, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 14:07. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 01 Mar 2027 16:00 | -0.05 | — | — | Upcoming |
| 04 Nov 2026 16:00 | -0.06 | -0.05 | +21.1% | Beat |
| 27 Jul 2026 16:00 | -0.11 | -0.03 | +76.3% | Beat |
| 28 Apr 2026 16:00 | -0.07 | -0.07 | -6.2% | Miss |
| 26 Feb 2026 16:00 | -0.07 | -0.04 | +48.9% | Beat |
| 29 Oct 2025 16:00 | -0.04 | 0.03 | +166.7% | Beat |
| 31 Jul 2025 16:00 | -0.10 | -0.08 | +17.9% | Beat |
| 30 Apr 2025 16:00 | -0.11 | -0.09 | +13.8% | Beat |
| 27 Feb 2025 16:00 | -0.10 | 0.01 | +110.0% | Beat |
| 07 Nov 2024 16:00 | -0.09 | 0.03 | +132.1% | Beat |
| 07 Aug 2024 16:00 | -0.09 | -0.01 | +89.5% | Beat |
| 07 May 2024 16:00 | -0.09 | -0.12 | -26.3% | Miss |
| 27 Feb 2024 16:00 | -0.10 | -0.09 | +10.0% | Beat |
| 06 Nov 2023 16:00 | -0.10 | -0.11 | -10.0% | Miss |
| 03 Aug 2023 16:00 | -0.07 | -0.03 | +58.1% | Beat |
| 03 May 2023 16:00 | -0.08 | -0.02 | +73.9% | Beat |
| 23 Feb 2023 16:00 | -0.11 | -0.11 | +1.5% | Beat |
| 08 Nov 2022 16:00 | -0.08 | -0.11 | -31.0% | Miss |
| 05 Aug 2022 13:00 | 0.03 | -0.14 | -660.0% | Miss |
| 09 May 2022 16:00 | -0.06 | -0.08 | -42.9% | Miss |
| 24 Feb 2022 16:00 | -0.02 | -0.11 | -450.0% | Miss |
| 28 Oct 2021 16:00 | -0.01 | 0.04 | +766.7% | Beat |
| 29 Jul 2021 16:00 | 0.02 | -0.03 | -266.7% | Miss |
| 28 Apr 2021 16:00 | 0.05 | 0.05 | +4.2% | Beat |
| 18 Feb 2021 16:00 | 0.04 | 0.05 | +19.1% | Beat |
| 29 Oct 2020 16:00 | 0.04 | 0.04 | -9.1% | Miss |
| 30 Jul 2020 16:00 | -0.07 | 0.05 | +175.8% | Beat |
| 06 May 2020 17:00 | -0.09 | -0.09 | 0.0% | In line |
| 26 Feb 2020 16:00 | -0.09 | -0.18 | -105.7% | Miss |
| 05 Nov 2019 16:00 | -0.09 | -0.11 | -22.2% | Miss |
| 07 Aug 2019 16:00 | -0.11 | -0.11 | +1.4% | Beat |
| 07 May 2019 16:00 | -0.11 | -0.13 | -13.0% | Miss |
| 27 Feb 2019 16:00 | -0.07 | -0.11 | -55.1% | Miss |
| 09 Nov 2018 16:00 | -0.06 | -0.05 | +16.7% | Beat |
| 07 Aug 2018 16:00 | -0.07 | -0.03 | +50.3% | Beat |
| 08 May 2018 16:00 | -0.13 | -0.08 | +38.5% | Beat |
| 01 Mar 2018 16:00 | -0.08 | -0.12 | -50.1% | Miss |
| 08 Nov 2017 16:00 | -0.05 | -0.08 | -52.2% | Miss |
| 08 Aug 2017 16:00 | -0.05 | -0.03 | +40.0% | Beat |
| 09 May 2017 16:00 | -0.04 | -0.06 | -50.0% | Miss |
| 01 Mar 2017 16:00 | -0.04 | -0.02 | +50.0% | Beat |
| 07 Nov 2016 16:00 | -0.02 | -0.02 | +28.0% | Beat |
| 08 Aug 2016 16:00 | -0.02 | -0.02 | +16.0% | Beat |
| 09 May 2016 16:00 | -0.02 | -0.03 | -20.0% | Miss |
| 29 Feb 2016 16:00 | 0.01 | — | -130.0% | — |
| 09 Nov 2015 16:00 | -0.02 | -0.03 | -44.3% | Miss |
| 05 Aug 2015 16:00 | -0.05 | — | +98.9% | — |
| 11 May 2015 16:00 | -0.08 | -0.09 | -14.9% | Miss |
| 27 Feb 2015 17:00 | -0.07 | -0.12 | -71.4% | Miss |
| 07 Nov 2014 08:00 | -0.09 | -0.11 | -22.2% | Miss |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 606.9M | -14.9% | -225.7M | -37.2% | -0.30 | -275.0% | -190.8M |
| 2024 | 713.1M | -17.4% | -53.2M | -7.5% | -0.08 | +68.0% | -208.5M |
| 2023 | 863.5M | -14.0% | -188.9M | -21.9% | -0.25 | +45.7% | -44.5M |
| 2022 | 1B | — | -328.4M | -32.7% | -0.46 | — | -119.8M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 09 Nov 2026 – 12 Nov 2026 In progress | 1.74 | 1.79 | 1.62 | 1.67 | -3.47% | 10,715,700 | |
| 02 Nov 2026 – 06 Nov 2026 | 1.68 | 1.86 | 1.67 | 1.73 | +4.22% | 28,750,700 | |
| 26 Oct 2026 – 30 Oct 2026 | 1.65 | 1.69 | 1.59 | 1.66 | +1.84% | 12,746,600 | |
| 19 Oct 2026 – 23 Oct 2026 | 1.55 | 1.73 | 1.53 | 1.63 | +6.54% | 14,852,300 | |
| 12 Oct 2026 – 16 Oct 2026 | 1.38 | 1.77 | 1.30 | 1.53 | +10.87% | 71,664,300 | |
| 05 Oct 2026 – 09 Oct 2026 | 1.56 | 1.59 | 1.34 | 1.38 | -11.54% | 9,887,000 | |
| 28 Sep 2026 – 02 Oct 2026 | 1.64 | 1.65 | 1.55 | 1.56 | -4.88% | 9,616,200 | |
| 21 Sep 2026 – 25 Sep 2026 | 1.67 | 1.75 | 1.62 | 1.64 | -1.80% | 11,268,200 | |
| 14 Sep 2026 – 18 Sep 2026 | 1.59 | 1.68 | 1.54 | 1.67 | +6.37% | 12,913,100 | |
| 08 Sep 2026 – 11 Sep 2026 | 1.63 | 1.63 | 1.47 | 1.57 | -4.27% | 10,619,900 | |
| 252 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Is OPKO Health (OPK) A Bargain As New Results And Guidance Reset Valuation? (opens in a new tab) Simply Wall St. · 08 Nov 2026 01:15
- How Investors May Respond To OPKO Health (OPK) Updated Revenue Guidance (opens in a new tab) Simply Wall St. · 08 Nov 2026 00:22
- OPKO Health (OPK) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 05 Nov 2026 15:13
- What OPKO Health (OPK) Said on Its Q3 Earnings Call (opens in a new tab) MarketBeat · 05 Nov 2026 06:14
- OPKO Health Inc (OPK) (Q3 2026) Earnings Call Highlights: Revenue Climbs 16% as LabCorp Deal ... (opens in a new tab) GuruFocus.com · 05 Nov 2026 05:20
- OPKO Health, Inc. (OPK) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 05 Nov 2026 00:06
- OPKO Health (OPK) Reports Q3 Loss, Misses Revenue Estimates (opens in a new tab) Zacks · 04 Nov 2026 23:45
- OPKO Health: Q3 Earnings Snapshot (opens in a new tab) Associated Press · 04 Nov 2026 22:07
- OPKO Health (OPK) Stock Looks Pricey As Focus Turns To Its 58% Five Year Fall (opens in a new tab) Simply Wall St. · 03 Nov 2026 06:09
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 1.71 USD
- Market cap
- 1.2B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Currency
- USD
Dividends
No dividends on record.
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Business growth Yearly growth of revenue and of earnings per share. | 0.0 / 25 |
|
| Quality Return on equity, net margin and how stable the margins are. | 0.0 / 25 |
|
| Financial strength Net debt against operating earnings, interest cover and free cash flow. | 0.0 / 20 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 7.5 / 15 |
|
| Analysts How far the analysts' average target is from today's price. | 10.0 / 10 |
|
- Score capped at 50: three or more warnings
- Thin interest cover: operating profit is only -2.0× the interest
- The last full year was a loss
- Revenue has fallen two years in a row
Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A). Warnings take 18 points off.
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio. How the score works
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (forward) | -4.99× | Weak | 14.16× |
| Price / book | 1.11× | Good | 3.5× |
| Price / sales | 1.9× | Good | 3.33× |
| EV / EBITDA | -15.26× | Weak | 11.19× |
| Free cash flow yield | -21.4% | Weak | 2.1% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 19.6% | Weak | 54.9% |
| Operating margin | -27.8% | Weak | 5.8% |
| Net margin | -22.6% | Weak | 1.2% |
| Return on equity | -8.9% | Weak | 4.4% |
| Return on assets | -5.9% | Weak | 2.7% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | -15.5% | Weak | 10.1% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 0.46× | Good | 0.4× |
| Interest cover | -2.02× | Weak | 2.17× |
| Current ratio | 4.97× | Good | 2.64× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 0% | Weak | 0% |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Similar shares
Follow OPK and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.